Córdova PVH, Peña SJ, Quintero BM

Idioma: Español
Referencias bibliográficas: 39
Paginas: 160-167
Archivo PDF: 329.40 Kb.

RESUMEN

El paciente en estado crítico, independiente de la causa que lo lleva a una unidad de cuidados intensivos, enfrenta una serie de factores de riesgo que pueden agravar su condición. De ellos, uno de los más costosos para la vida y la función es la neumonía asociada con la ventilación necesaria para soportar su vida. En esta revisión se presentan diversos aspectos del tema y se resume una visión internacional actual. Se sugieren algunas conductas avaladas por organismos de expertos para facilitar al médico internista su abordaje diagnóstico y terapéutico.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Rello J, Diaz E. Pneumonia in the intensive care unit. Crit Care Med 2003;31(10):2544-2551.

2. Lerroy O, et al. Hospital-Acquired Pneumonia Risk Factors for Antimicrobial-Resistant Causative Pathogens in Critically Ill Patients. Chest 2003;123(6):2034-2042

3. Lynch III, Joseph P. Hospital-acquired pneumonia risk factors, microbiology, and treatment. Chest 2001;119(2):373S-383S.

4. Laupland KB, et al. Population-based assessment of intensive care unit-acquired bloodstream infections in adults: Incidence, risk factors, and associated mortality rate. Crit Care Med 2002;30(11):2462-2467.

5. Centers for Disease Control and Prevention. Guidelines for prevention of nosocomial pneumonia. MMWR 1997;46(RR-1):9.

6. Ravindra MM, Niederman MS. Nosocomial pneumonia. Current Opinion in Infectious Diseases 2002;(15):387-394.

7. Rello J, et al. Incidence, etiology, and outcome of nosocomial pneumonia in icu patients requiring percutaneous tracheotomy for mechanical ventilation. Chest 2003;124(6):2239-2243.

8. Glen CM. Ventilator-Associated Pneumonia or Not? Contemporary Diagnosis. Emerging Infectious Diseases 2001;7(2).

9. Tejada-Artigas A, et al. Risk factors for nosocomial pneumonia in critically ill trauma patients. Crit Care Med 2001;29(2):304-309.

10. Rello J, et al. Epidemiology and outcomes of ventilatorassociated pneumonia in a large US Database. Chest 2002;122(6):2115-2121.

11. Kunis K, et al. Ventilator-associated Pneumonia in the ICU. AJN 2003;103(8):64AA-64DD.

12. Principi N, Esposito S. Ventilator-associated Pneumonia (VAP) in Pediatric Intensive Care Units. Pediatr Infect Dis J 2007;27:841-843.

13. Robbins RA, et al. Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia. A preliminary report. Chest 2007;132:58-63.

14. ATS Guidelines for the management of adults with hospitalacquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171: 388-416.

15. Craven D, et al. Ventilator-associated tracheobronchitis, the impact of targeted antibiotic therapy on patient outcomes. Chest 2009;135:521-528.

16. Thiago L, et al. The ventilator-associated pneumonia PIRO Score. Chest 2008;134:1208-1216.

17. Powers J, et al. Impact of oral hygiene on prevention of ventilator-associated pneumonia in neuroscience patients J Nurs Care Qual 2001;22;4:316-321.

18. Schuetz P et al. Biomarkers to improve diagnostic and prognostic accuracy in systemic infections. Curr Op in Crit Care 2007;13:578-585.

19. Fabregas N, et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999;54:867-873.

20. Baughman R. Diagnosis of ventilator-associated pneumonia. Curr Op in Crit Care 2003;9:397-402.

21. Luna C, et al. Resolution of ventilator-associated pneumonia: Prospective evaluation of the clinical pulmonary infection score as an early clinical predictor outcome. Crit Care Med 2003;31(3):676-682.

22. Rea-Nieto A, et al. Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Critical Care 2008;12:R56.

23. Grigory H, et al. Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia. Chest 2007;132:58-63.

24. Nitin JA, et al. Diagnostic Implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest 2009;135:641-647.

25. Marin HK, et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia. JAMA 2008;300(7):805-812.

26. Chastre J. Preventing ventilator-associated Pneumonia. Could Silver-Coated Endotraqueal Tubes Be The Answer? JAMA 2008;300(7):842-844.

27. Charlotte L, DePew, McCarthy MS. Subglottic secretion drainage a literature review. AACN Advanced Critical Care 2007;18(4):366-379.

28. Dragoumanis Ch, et al. Investigating the failure to aspirate subglottic secretions with the EVAC endotraqueal tube. Anesthesia Analgesia 2007;105(4):1083-1084.

29. Torres A, Serra-Batlles J, et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med 1992;116:540-543.

30. Orozco-Levi M, et al. Semirecumbent position protects from pulmonary aspiration but not completely from gastroesophageal reflux in mechanically ventilated patients. Am J Respir Crit Care Med 1995;152:1387-1390.

31. Heyland DK, et al. Effect of postpyloric feeding on gastroesophageal regurgitation and pulmonary microaspiration: results of a randomized controlled trial. Crit Care Med 2001;29:1495-1501.

32. Loreto V, et al. Ventilator-associated Pneumonia. Impact of organisms on clinical resolution and medical resources utilization. Chest 2008;133:625-632.

33. Garnacho-Montero J, et al. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy. Crit Care Med 2007;35(8):1888-1895.

34. Wunderink R, et al. Early microbiological response to linezolid vs vancomycin in ventilator-associated pnemonia due to methicillin-resistant Staphylococcus aureus. Chest 2008; 134:1200-1207.

35. Luna C, et al. Resolution of ventilator-associated pneumonia: Prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003;31(3):676-682.

36. Kollef K, et al. Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic resistant gram-negative bacteria. Chest 2008;134:281-287.

37. Luna C, et al. Impact of BAL data on the therapy and outcome of ventilator associated pneumonia. Chest 1997;111:676-685.